[The antioxidative and inflammation inhibiting properties of ambroxol].
Winsel
K
K
Fachkrankenhaus für Lungenheilkunde und Thoraxchirurgie, Berlin-Buch.
D000551:Ambroxol / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000818:Animals; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000975:Antioxidants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D015227:Lipid Peroxidation / Q000187:drug effects* / Q000502:physiology; D008173:Lung Diseases, Obstructive / Q000097:blood / Q000188:drug therapy*; D016676:Macrophages, Alveolar / Q000187:drug effects / Q000502:physiology; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000975:Antioxidants; D000551:Ambroxol
Antioxidative und entzündungshemmende Eigenschaften von Ambroxol.